March 28, 2024
Loading...
You are here:  Home  >  'MannKind'
Latest

MannKind reports loss but record revenue for Q3

By   /  Tuesday, November 8th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Tri-County Public Companies, Ventura County  /  Comments Off on MannKind reports loss but record revenue for Q3

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

MannKind reports Q2 loss but beats revenue expectations

By   /  Friday, August 12th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on MannKind reports Q2 loss but beats revenue expectations

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

MannKind takes next step in rebuild with new FDA approval

By   /  Wednesday, May 25th, 2022  /  Latest news, middle, Regions, Subscriber content, Top Stories, Ventura County  /  Comments Off on MannKind takes next step in rebuild with new FDA approval

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

MannKind adds to diabetes treatment portfolio with $10M acquisition

By   /  Tuesday, May 17th, 2022  /  Banking & Finance, Health Care & Life Science, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on MannKind adds to diabetes treatment portfolio with $10M acquisition

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Revenue down and losses up at MannKind

By   /  Wednesday, May 11th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Revenue down and losses up at MannKind

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

MannKind shares at lowest since 2020 after earnings report

By   /  Tuesday, March 1st, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on MannKind shares at lowest since 2020 after earnings report

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Revenue and losses both growing at MannKind

By   /  Tuesday, August 17th, 2021  /  Banking & Finance, Earnings, East Ventura County, Health Care & Life Science, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Revenue and losses both growing at MannKind

MannKind saw a significant rise in revenue thanks to its product Afrezza, but its net loss in the second quarter of fiscal year 2021 also rose significantly as the company tried to pay down its debt. The Westlake Village biotech company released its earnings after the markets closed on Aug. 11. It opened the next Read More →